USD 16.78
(-1.64%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 73.04 Million | 25.14 Million | 41.31 Million | 7.52 Million | -1.61 Million | 8.26 Million |
Net Income | 75.93 Million | 17.28 Million | 27.26 Million | 2.14 Million | 7.28 Million | 1.43 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -6.34 Million | -19.09 Million | 20.54 Million | 1.95 Million | -8.75 Million | 6.44 Million |
Other non-cash items | 10.85 Million | 51.3 Million | -26.94 Million | 1.3 Million | 8.6 Million | -6.06 Million |
Investing Cash Flow | -442.57 Million | -452.98 Million | -429.61 Million | -159.25 Million | -15.84 Million | -162.05 Million |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -589 Million | -502.25 Million | -610.69 Million | -211.19 Million | -107.12 Million | -173.51 Million |
Sales/Maturities of investments | 146.42 Million | 49.26 Million | 181.07 Million | 51.94 Million | 91.27 Million | 11.45 Million |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 397.65 Million | 431.92 Million | 411.69 Million | 161.33 Million | 19.16 Million | 156.12 Million |
Debt repayment | -241.94 Million | -291.99 Million | -217.2 Million | -69.61 Million | -30.99 Million | -86.81 Million |
Dividends payments | -63.19 Million | -34.65 Million | -14.71 Million | -3.27 Million | -5.62 Million | -882 Thousand |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 218.89 Million | 174.58 Million | 209.2 Million | 94.99 Million | -6.19 Million | 70.2 Million |
Other Financing Activities | -4.48 Million | - | - | - | - | - |
Accounts receivables | -7.82 Million | -1.15 Million | -6.18 Million | 1.52 Million | -3.53 Million | 308 Thousand |
Accounts payables | 430 Thousand | -23.19 Million | 26.63 Million | 595 Thousand | -5.22 Million | 6.13 Million |
Inventory | - | - | - | - | - | - |
Other working capital | 1.05 Million | 5.25 Million | 102 Thousand | -166 Thousand | - | - |
Cash at beginning of period | 39.32 Million | 35.18 Million | 12.6 Million | 3.42 Million | 2.23 Million | -104 Thousand |
Cash at end of period | 67.44 Million | 39.32 Million | 35.18 Million | 12.6 Million | 3.42 Million | 2.23 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 28.12 Million | 4.13 Million | 22.57 Million | 9.18 Million | 1.18 Million | 2.34 Million |
Free Cash Flow | 73.04 Million | 25.14 Million | 41.31 Million | 7.52 Million | -1.61 Million | 8.26 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 30.02 Million | 28.76 Million | 75.93 Million | 20.14 Million | 14.3 Million | 12.71 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 23.99 Million | -3.59 Million | -6.34 Million | -4.76 Million | -674 Thousand | 2.68 Million |
Other non-cash items | -25.05 Million | -3.48 Million | 10.85 Million | 6.76 Million | 5.15 Million | 2.43 Million |
Investing Cash Flow | -149.43 Million | -155.54 Million | -442.57 Million | -130.37 Million | -96.34 Million | -60.31 Million |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -204.32 Million | -236.11 Million | -589 Million | -150.86 Million | -102.1 Million | -99.91 Million |
Sales/Maturities of investments | 54.89 Million | 80.57 Million | 146.42 Million | 20.49 Million | 5.75 Million | 39.6 Million |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 94.3 Million | 166.13 Million | 397.65 Million | 104.84 Million | 75.3 Million | 51.36 Million |
Debt repayment | -128.01 Million | -82.95 Million | -241.94 Million | -41.1 Million | -54.39 Million | -63.5 Million |
Dividends payments | -19.33 Million | -16.73 Million | -63.19 Million | -14.78 Million | -19.07 Million | -12.61 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 241.65 Million | 99.9 Million | 218.89 Million | 78.53 Million | 39.98 Million | 473 Thousand |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | 5.1 Million | -57 Thousand | -7.82 Million | -6.82 Million | -1.22 Million | 278 Thousand |
Accounts payables | 17.81 Million | -796 Thousand | 430 Thousand | 727 Thousand | -643 Thousand | 1.14 Million |
Inventory | - | - | - | - | - | - |
Other working capital | 1.08 Million | -2.73 Million | 1.05 Million | 1.34 Million | 1.19 Million | 1.26 Million |
Cash at beginning of period | 67.44 Million | 36.02 Million | 39.32 Million | 45.49 Million | 49.61 Million | 39.32 Million |
Cash at end of period | 64.19 Million | 67.44 Million | 67.44 Million | 36.02 Million | 45.49 Million | 49.61 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -3.24 Million | 31.42 Million | 28.12 Million | -9.47 Million | -4.12 Million | 10.29 Million |
Free Cash Flow | 51.87 Million | 20.83 Million | 73.04 Million | 16.05 Million | 16.91 Million | 19.24 Million |
GM
AGL
ADORWELD
BIO
0TZZ
GODREJIND